Targeted lung denervation in the healthy sheep model - A potential treatment for COPD

M. Mayse, P. Johnson, J. Streeter, M. Deem, J. Hummel (Minneapolis, Menlo Park, Chapel Hill, United States Of America)

Source: International Congress 2014 – Rationale behind respiratory drug development
Session: Rationale behind respiratory drug development
Session type: Thematic Poster Session
Number: 943
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Mayse, P. Johnson, J. Streeter, M. Deem, J. Hummel (Minneapolis, Menlo Park, Chapel Hill, United States Of America). Targeted lung denervation in the healthy sheep model - A potential treatment for COPD. Eur Respir J 2014; 44: Suppl. 58, 943

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Importance of surface cooling during targeted lung denervation for COPD
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

Cost-effectiveness of bronchial thermoplasty (BT) treatment relative to no BT treatment option for patients with severe asthma
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014

Anti-inflammatory effects of targeted lung denervation in patients with COPD
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014

Efficacy of targeted lung denervation in patients with moderate to severe COPD
Source: International Congress 2014 – Bronchoscopic treatment of emphysema: where are we?
Year: 2014

Distribution and outcomes of the new Spanish phenotype-based guideline for COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016


Safety and feasibility of targeted lung denervation in patients with moderate to severe COPD
Source: International Congress 2014 – Bronchoscopic treatment of emphysema: valves, coils and other
Year: 2014

Bilateral targeted lung denervation in patients with COPD in a single procedure
Source: International Congress 2014 – Bronchoscopic treatment of emphysema: where are we?
Year: 2014


Effect of aclidinium/formoterol fixed-dose combinations on respiratory symptoms in COPD patients
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Development of a human COPD model-on-a-chip to mimic disease exacerbation (a small airway-on-a-chip model)
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014

The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Analyzing the pathway to triple therapy in COPD patients: A retrospective database analysis
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Local effect of airway clearance techniques in COPD patients
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014

Short-term effects of bronchial thermoplasty on pulmonary function in patients with severe asthma
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016

Is therapy adherence to inhaled corticosteroids related to hospitalization, pneumonia or mortality in COPD?
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Is therapy adherence with inhaled tiotropium in COPD related to hospitalization, pneumonia or mortality?
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Endobronchial ultrasound in study of airway wall remodeling in COPD patients
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Effectiveness of a comprehensive management program of fragile COPD patients
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014



Prediction of asthma control and treatment changes in obstructive asthmatic children
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016